Cargando…
HDL in sepsis – risk factor and therapeutic approach
High-density lipoprotein (HDL) is a key component of circulating blood and plays essential roles in regulation of vascular endothelial function and immunity. Clinical data demonstrate that HDL levels drop by 40–70% in septic patients, which is associated with a poor prognosis. Experimental studies u...
Autores principales: | Morin, Emily E., Guo, Ling, Schwendeman, Anna, Li, Xiang-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616240/ https://www.ncbi.nlm.nih.gov/pubmed/26557091 http://dx.doi.org/10.3389/fphar.2015.00244 |
Ejemplares similares
-
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
por: Morin, Emily E., et al.
Publicado: (2018) -
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020) -
HDL and glucose metabolism: current evidence and therapeutic potential
por: Siebel, Andrew L., et al.
Publicado: (2015) -
Editorial: Sepsis: Basic, Clinical and Therapeutic Approaches
por: Kang, Yan, et al.
Publicado: (2022) -
Sepsis-induced AKI: From pathogenesis to therapeutic approaches
por: He, Fang-Fang, et al.
Publicado: (2022)